Anti-tissue factor antibodies and compositions
Isolated anti-tissue factor antibodies, immunoglobulins, cleavage products and other specified portions and variants thereof having enhanced ADCC activity, as well as anti-tissue factor antibody compositions, encoding or complementary nucleic acids, vectors, host cells, compositions, formulations, devices, transgenic animals, transgenic plants, and methods of making and using thereof. The antibodies of the invention bind human tissue factor and demonstrate enhanced ADCC activity. Accordingly, the antibodies can be used in a variety of methods for diagnosing, treating, and/or preventing diseases involving tissue factor, where enhanced ADCC activity is desirable such as cancer.
1. An isolated nucleic acid encoding the isolated anti-tissue factor antibody having a light chain sequence of SEQ ID No. 4 and a heavy chain sequence of SEQ ID NO. 2.
2. An isolated nucleic acid vector comprising an isolated nucleic acid according to claim 1 .
3. A transfectoma comprising the isolated nucleic acid of claim 1 .
4. A prokaryotic or eukaryotic host cell comprising an isolated nucleic acid according to claim 1 .
5. A host cell according to claim 4 , wherein said host cell is at least one selected from COS-1, COS-7, HEK293, BHK21, CHO, BSC-1, Hep G2, 653, SP2/0, 293, HeLa, myeloma, lymphoma cells, Perc.6, or any derivative, immortalized or transformed cell thereof.
6. A method for producing at least one anti-tissue factor antibody, comprising translating a nucleic acid according to claim 1 under conditions in vitro, in vivo or in situ, such that the tissue factor antibody is expressed in detectable or recoverable amounts.